Loss of vinculin and membrane-bound β-catenin promotes metastasis and predicts poor prognosis in colorectal cancer

Molecular Cancer

Volumn 13, Issue 1, 2014, Pages

  Li, Ting ^a   Guo, Hanqing ^b   Song, Ying ^b   Zhao, Xiaodi ^a   Shi, Yongquan ^a   Lu, Yuanyuan ^a   Hu, Sijun ^a   Nie, Yongzhan ^a   Fan, Daiming ^a   Wu, Kaichun ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Colorectal cancer; EMT; Metastasis; Prognosis; Vinculin; catenin

Indexed keywords

BETA CATENIN; LENTIVIRUS VECTOR; SMALL INTERFERING RNA; TUMOR MARKER; VINCULIN; CTNNB1 PROTEIN, HUMAN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; CANCER PROGNOSIS; CANCER SURVIVAL; CELL INVASION; CELL MEMBRANE; CELL MIGRATION; COLORECTAL CANCER; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; MOUSE; NONHUMAN; PHENOTYPE; REAL TIME POLYMERASE CHAIN REACTION; TRANSWELL ASSAY; WESTERN BLOTTING; ANIMAL; CACO 2 CELL LINE; CELL MOTION; COLORECTAL NEOPLASMS; HCT116 CELL LINE; HT 29 CELL LINE; METABOLISM; MIDDLE AGED; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; TUMOR CELL LINE;

ANIMALS; BETA CATENIN; CACO-2 CELLS; CELL LINE, TUMOR; CELL MOVEMENT; COLORECTAL NEOPLASMS; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HCT116 CELLS; HT29 CELLS; HUMANS; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; VINCULIN;

EID: 84924415907     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-13-263     Document Type: Article

References (51)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011, 61:69-90. 10.3322/caac.20107
2. Center MM, Jemal A, Smith RA, Ward E: Worldwide variations in colorectal cancer. CA Cancer J Clin 2009, 59:366-378. 10.3322/caac.20038
3. Mitry E, Bouvier AM, Esteve J, Faivre J: Benefit of operative mortality reduction on colorectal cancer survival. Br J Surg 2002, 89:1557-1562. 10.1046/j.1365-2168.2002.02276.x
4. Hanahan D, Weinberg RA: Hallmarks of cancer: the next generation. Cell 2011, 144:646-674. 10.1016/j.cell.2011.02.013
5. Cavallaro U, Christofori G: Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 2004, 4:118-132. 10.1038/nrc1276
6. Ziegler WH, Liddington RC, Critchley DR: The structure and regulation of vinculin. Trends Cell Biol 2006, 16:453-460. 10.1016/j.tcb.2006.07.004
7. Humphries JD, Wang P, Streuli C, Geiger B, Humphries MJ, Ballestrem C: Vinculin controls focal adhesion formation by direct interactions with talin and actin. J Cell Biol 2007, 179:1043-1057. 10.1083/jcb.200703036
8. Subauste MC, Pertz O, Adamson ED, Turner CE, Junger S, Hahn KM: Vinculin modulation of paxillin-FAK interactions regulates ERK to control survival and motility. J Cell Biol 2004, 165:371-381. 10.1083/jcb.200308011
9. Wen KK, Rubenstein PA, DeMali KA: Vinculin nucleates actin polymerization and modifies actin filament structure. J Biol Chem 2009, 284:30463-30473. 10.1074/jbc. M109.021295
10. Carisey A, Tsang R, Greiner AM, Nijenhuis N, Heath N, Nazgiewicz A, Kemkemer R, Derby B, Spatz J, Ballestrem C: Vinculin regulates the recruitment and release of core focal adhesion proteins in a force-dependent manner. Curr Biol 2013, 23:271-281. 10.1016/j.cub.2013.01.009
11. Kawahara E, Tokuda R, Nakanishi I: Migratory phenotypes of HSC-3 squamous carcinoma cell line induced by EGF and PMA: relevance to migration of loosening of adhesion and vinculin-associated focal contacts with prominent filopodia. Cell Biol Int 1999, 23:163-174. 10.1006/cbir.1998.0331
12. Lifschitz-Mercer B, Czernobilsky B, Feldberg E, Geiger B: Expression of the adherens junction protein vinculin in human basal and squamous cell tumors: relationship to invasiveness and metastatic potential. Hum Pathol 1997, 28:1230-1236. 10.1016/S0046-8177(97)90195-7
13. Meyer T, Brinck U: Immunohistochemical detection of vinculin in human rhabdomyosarcomas. Gen Diagn Pathol 1997, 142:191-198.
14. Somiari RI, Sullivan A, Russell S, Somiari S, Hu H, Jordan R, George A, Katenhusen R, Buchowiecka A, Arciero C, Brzeski H, Hooke J, Shriver C: High-throughput proteomic analysis of human infiltrating ductal carcinoma of the breast. Proteomics 2003, 3:1863-1873. 10.1002/pmic.200300560
15. Yang HJ, Chen JZ, Zhang WL, Ding YQ: Focal adhesion plaque associated cytoskeletons are involved in the invasion and metastasis of human colorectal carcinoma. Cancer Invest 2010, 28:127-134. 10.3109/07357900903147184
16. Coll JL, Ben-Ze'Ev A, Ezzell RM, Rodriguez FJ, Baribault H, Oshima RG, Adamson ED: Targeted disruption of vinculin genes in F9 and embryonic stem cells changes cell morphology, adhesion, and locomotion. Proc Natl Acad Sci U S A 1995, 92:9161-9165. 10.1073/pnas.92.20.9161
17. Rodriguez FJ, Geiger B, Salomon D, Sabanay I, Zoller M, Ben-Ze'Ev A: Suppression of tumorigenicity in transformed cells after transfection with vinculin cDNA. J Cell Biol 1992, 119:427-438. 10.1083/jcb.119.2.427
18. Gu S, Papadopoulou N: Activation of membrane androgen receptors in colon cancer inhibits the prosurvival signals Akt/Bad InVitroand InVivoand blocks migration via Vinculin/Actin signaling. Mol Med 2011, 17:1.
19. Bakolitsa C, Cohen DM, Bankston LA, Bobkov AA, Cadwell GW, Jennings L, Critchley DR, Craig SW, Liddington RC: Structural basis for vinculin activation at sites of cell adhesion. Nature 2004, 430:583-586. 10.1038/nature02610
20. Bois PR, O'Hara BP, Nietlispach D, Kirkpatrick J, Izard T: The vinculin binding sites of talin and alpha-actinin are sufficient to activate vinculin. J Biol Chem 2006, 281:7228-7236. 10.1074/jbc. M510397200
21. Imamura Y, Itoh M, Maeno Y, Tsukita S, Nagafuchi A: Functional domains of alpha-catenin required for the strong state of cadherin-based cell adhesion. J Cell Biol 1999, 144:1311-1322. 10.1083/jcb.144.6.1311
22. Hazan RB, Kang L, Roe S, Borgen PI, Rimm DL: Vinculin is associated with the E-cadherin adhesion complex. J Biol Chem 1997, 272:32448-32453. 10.1074/jbc.272.51.32448
23. Peng X, Cuff LE, Lawton CD, DeMali KA: Vinculin regulates cell-surface E-cadherin expression by binding to beta-catenin. J Cell Sci 2010, 123:567-577. 10.1242/jcs.056432
24. Lal M, Song X, Pluznick JL, Di Giovanni V, Merrick DM, Rosenblum ND, Chauvet V, Gottardi CJ, Pei Y, Caplan MJ: Polycystin-1 C-terminal tail associates with beta-catenin and inhibits canonical Wnt signaling. Hum Mol Genet 2008, 17:3105-3117. 10.1093/hmg/ddn208
25. Stemmer V, de Craene B, Berx G, Behrens J: Snail promotes Wnt target gene expression and interacts with beta-catenin. Oncogene 2008, 27:5075-5080. 10.1038/onc.2008.140
26. Clevers H, Nusse R: Wnt/beta-catenin signaling and disease. Cell 2012, 149:1192-1205. 10.1016/j.cell.2012.05.012
27. Sanchez-Tillo E, de Barrios O, Siles L, Cuatrecasas M, Castells A, Postigo A: beta-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness. Proc Natl Acad Sci U S A 2011, 108:19204-19209. 10.1073/pnas.1108977108
28. Dorudi S, Sheffield JP, Poulsom R, Northover JM, Hart IR: E-cadherin expression in colorectal cancer: an immunocytochemical and in situ hybridization study. Am J Pathol 1993, 142:981-986.
29. Ngan CY, Yamamoto H, Seshimo I, Tsujino T, Man-i M, Ikeda JI, Konishi K, Takemasa I, Ikeda M, Sekimoto M, Matsuura N, Monden M: Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer. Br J Cancer 2007, 96:986-992. 10.1038/sj.bjc.6603651
30. Ramesh S, Nash J, McCulloch PG: Reduction in membranous expression of beta-catenin and increased cytoplasmic E-cadherin expression predict poor survival in gastric cancer. Br J Cancer 1999, 81:1392-1397. 10.1038/sj.bjc.6693437
31. Stanczak A, Stec R, Bodnar L, Olszewski W, Cichowicz M, Kozlowski W, Szczylik C, Pietrucha T, Wieczorek M, Lamparska-Przybysz M: Prognostic significance of Wnt-1, beta-catenin and E-cadherin expression in advanced colorectal carcinoma. Pathol Oncol Res 2011, 17:955-963. 10.1007/s12253-011-9409-4
32. Hewitt RE, McMarlin A, Kleiner D, Wersto R, Martin P, Tsokos M, Stamp GW, Stetler-Stevenson WG: Validation of a model of colon cancer progression. J Pathol 2000, 192:446-454. 10.1002/1096-9896(2000)9999:9999<::AID-PATH775>3.0.CO;2-K
33. Valastyan S, Weinberg RA: Tumor metastasis: molecular insights and evolving paradigms. Cell 2011, 147:275-292. 10.1016/j.cell.2011.09.024
34. Xu W, Baribault H, Adamson ED: Vinculin knockout results in heart and brain defects during embryonic development. Development 1998, 125:327-337.
35. Mierke CT, Kollmannsberger P, Paranhos Zitterbart D, Smith J, Fabry B, Goldmann WH: Mechano-coupling and regulation of contractility by the vinculin tail domain. Biophys J 2008, 94:661-670. 10.1529/biophysj.107.108472
36. Mierke CT, Kollmannsberger P, Zitterbart DP, Diez G, Koch TM, Marg S, Ziegler WH, Goldmann WH, Fabry B: Vinculin facilitates cell invasion into three-dimensional collagen matrices. J Biol Chem 2010, 285:13121-13130. 10.1074/jbc. M109.087171
37. Chen H, Choudhury DM, Craig SW: Coincidence of actin filaments and talin is required to activate vinculin. J Biol Chem 2006, 281:40389-40398. 10.1074/jbc. M607324200
38. Subauste MC, Nalbant P, Adamson ED, Hahn KM: Vinculin controls PTEN protein level by maintaining the interaction of the adherens junction protein beta-catenin with the scaffolding protein MAGI-2. J Biol Chem 2005, 280:5676-5681. 10.1074/jbc. M405561200
39. Ray S, Foote HP, Lechler T: beta-Catenin protects the epidermis from mechanical stresses. J Cell Biol 2013, 202:45-52. 10.1083/jcb.201212140
40. Solanas G, Porta-de-la-Riva M, Agusti C, Casagolda D, Sanchez-Aguilera F, Larriba MJ, Pons F, Peiro S, Escriva M, Munoz A, Dunach M, De Herreros AG, Baulida J: E-cadherin controls beta-catenin and NF-kappaB transcriptional activity in mesenchymal gene expression. J Cell Sci 2008, 121:2224-2234. 10.1242/jcs.021667
41. Kinugasa T, Akagi Y, Ochi T, Tanaka N, Kawahara A, Ishibashi Y, Gotanda Y, Yamaguchi K, Shiratuchi I, Oka Y, Kage M, Shirouzu K: Increased claudin-1 protein expression in hepatic metastatic lesions of colorectal cancer. Anticancer Res 2012, 32:2309-2314.
42. Morikawa T, Kuchiba A, Yamauchi M, Meyerhardt JA, Shima K, Nosho K, Chan AT, Giovannucci E, Fuchs CS, Ogino S: Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer. JAMA 2011, 305:1685-1694. 10.1001/jama.2011.513
43. Choi HN, Kim KR, Lee JH, Park HS, Jang KY, Chung MJ, Hwang SE, Yu HC, Moon WS: Serum response factor enhances liver metastasis of colorectal carcinoma via alteration of the E-cadherin/beta-catenin complex. Oncol Rep 2009, 21:57-63.
44. Shook D, Keller R: Mechanisms, mechanics and function of epithelial-mesenchymal transitions in early development. Mech Dev 2003, 120:1351-1383. 10.1016/j.mod.2003.06.005
45. Polyak K, Weinberg RA: Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 2009, 9:265-273. 10.1038/nrc2620
46. Yilmaz M, Christofori G: EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 2009, 28:15-33. 10.1007/s10555-008-9169-0
47. Li T, Lu YY, Zhao XD, Guo HQ, Liu CH, Li H, Zhou L, Han YN, Wu KC, Nie YZ, Shi YQ, Fan DM: MicroRNA-296-5p increases proliferation in gastric cancer through repression of Caudal-related homeobox 1. Oncogene 2014, 33:783-793. 10.1038/onc.2012.637
48. Zhao X, Dou W, He L, Liang S, Tie J, Liu C, Li T, Lu Y, Mo P, Shi Y, Wu K, Nie Y, Fan D: MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor. Oncogene 2013, 32:1363-1372. 10.1038/onc.2012.156
49. Salim T, Sjolander A, Sand-Dejmek J: Nuclear expression of glycogen synthase kinase-3beta and lack of membranous beta-catenin is correlated with poor survival in colon cancer. Int J Cancer 2013, 133:807-815. 10.1002/ijc.28074
50. Neumann J, Horst D, Kriegl L, Maatz S, Engel J, Jung A, Kirchner T: A simple immunohistochemical algorithm predicts the risk of distant metastases in right-sided colon cancer. Histopathology 2012, 60:416-426. 10.1111/j.1365-2559.2011.04126.x
51. Uchikado Y, Natsugoe S, Okumura H, Setoyama T, Matsumoto M, Ishigami S, Aikou T: Slug Expression in the E-cadherin preserved tumors is related to prognosis in patients with esophageal squamous cell carcinoma. Clin Cancer Res 2005, 11:1174-1180.